SEngine Testing Specific Drug Combinations for Individualized Cancer Cells

Поделиться
HTML-код
  • Опубликовано: 19 авг 2018
  • Dr. Carla Grandori and her team at SEngine Precision Medicine describe their goal to target and find specific vulnerability of individualized cancer cells by using the Echo acoustic liquid handling technology to test drug combination treatments and provide meaningful recommendations to oncologists
  • НаукаНаука

Комментарии •